Prenylated flavonoids from Morus alba L. Cause Inhibition of G1/S transition in THP-1 human leukemia cells and prevent the lipopolysaccharide- induced inflammatory response

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Kollar, Peter ^a   Bárta, Tomáš ^b   Hošek, Jan ^a   Souček, Karel ^c,d   Závalová, Veronika Müller ^a   Artinian, Shushan ^e   Talhouk, Rabih ^e   Šmejkal, Karel ^a   Suchý, Pavel ^a   Hampl, Aleš ^b,d  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

4' O METHYLKUWANON E; CUDRAFLAVONE B; FLAVONOID; KUWANON E; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL; MORUS ALBA; PRIORITY JOURNAL; REVIEW; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84878699554     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/350519     Document Type: Review

References (42)

1. Ercisli S., Orhan E., Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits. Food Chemistry 2007 103 4 1380 1384 2-s2.0-33947536879 10.1016/j.foodchem.2006.10.054 (Pubitemid 46467134)
2. Hošek J., Bartos M., Chudík S., Dall'Acqua S., Innocenti G., Kartal M., Kokoška L., Kollár P., Kutil Z., Landa P., Marek R., Závalová V., Žemlicčka M., Šmejkal K., Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro. Journal of Natural Products 2011 74 4 614 619 2-s2.0-79955394489 10.1021/np100638h
3. Sohn H. Y., Son K. H., Kwon C. S., Kwon G. S., Kang S. S., Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 2004 11 7-8 666 672 2-s2.0-10844277473 10.1016/j.phymed.2003.09.005 (Pubitemid 40007752)
4. Du J., He Z. D., Jiang R. W., Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry 2003 62 8 1235 1238 2-s2.0-0037380166 10.1016/S0031-9422(02)00753-7 (Pubitemid 36383593)
5. El-Beshbishy H. A., Singab A. N. B., Sinkkonen J., Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sciences 2006 78 23 2724 2733 2-s2.0-33646841321 10.1016/j.lfs.2005.10.010 (Pubitemid 44316667)
6. Oh H., Ko E. K., Jun J. Y., Oh M. H., Park S. U., Kang K. H., Lee H. S., Kim Y. C., Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba. Planta Medica 2002 68 10 932 934 2-s2.0-0036775028 10.1055/s-2002-34930 (Pubitemid 35239287)
7. Nam S. Y., Yi H. K., Lee J. C., Jae C. K., Chang H. S., Jin W. P., Dae Y. L., Jung S. K., Pyoung H. H., Cortex mori extract induces cancer cell apoptosis through inhibition of microtubule assembly. Archives of Pharmacal Research 2002 25 2 191 196 2-s2.0-0036547668 (Pubitemid 43057314)
8. Dat N. T., Binh P. T. X., Quynh L. T. P., Cytotoxic prenylated flavonoids from Morus alba. Fitoterapia 2010 81 8 1224 1227 2-s2.0-78549287080 10.1016/j.fitote.2010.08.006
9. Lee J. C., Won S. J., Chao C. L., Wu F. L., Liu H. S., Ling P., Lin C. N., Su C. L., Morusin induces apoptosis and suppresses NF- B activity in human colorectal cancer HT-29 cells. Biochemical and Biophysical Research Communications 2008 372 1 236 242 2-s2.0-46549090195 10.1016/j.bbrc.2008.05.023
10. Kikuchi T., Nihei M., Nagai H., Fukushi H., Tabata K., Suzuki T., Akihisa T., Albanol A from the root bark of Morus alba L. induces apoptotic cell death in HL60 human leukemia cell line. Chemical & Pharmaceutical Bulletin 2010 58 4 568 571 2-s2.0-77950856319 10.1248/cpb.58.568
11. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
12. Wu Y., Zhou B. P., TNF- α /NF B/Snail pathway in cancer cell migration and invasion. British Journal of Cancer 2010 102 4 639 644 2-s2.0-76949084622 10.1038/sj.bjc.6605530
13. Hussain S. P., Harris C. C., Inflammation and cancer: an ancient link with novel potentials. International Journal of Cancer 2007 121 11 2373 2380 2-s2.0-35648983903 10.1002/ijc.23173 (Pubitemid 350022405)
14. Šmejkal K., Svačinová J., Šlapetová T., Schneiderová K., Dall'Acqua S., Innocenti G., Závalová V., Kollár P., Chudík S., Marek R., Julínek O., Urbanová M., Kartal M., Csöllei M., Doležal K., Cytotoxic activities of several geranyl-substituted flavanones. Journal of Natural Products 2010 73 4 568 572 2-s2.0-77951539852 10.1021/np900681y
15. Kollár P., Bárta T., Závalová V., Šmejkal K., Hampl A., Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells. British Journal of Pharmacology 2011 162 7 1534 1541 2-s2.0-79952370528 10.1111/j.1476-5381.2010. 01171.x
16. Safieh-Garabedian B., Mouneimne G. M., El-Jouni W., Khattar M., Talhouk R., The effect of endotoxin on functional parameters of mammary CID-9 cells. Reproduction 2004 127 3 397 406 2-s2.0-1842538841 (Pubitemid 38425699)
17. Pencikova K., Kollar P., Muller Zavalova V., Taborska E., Urbanova J., Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line. Phytomedicine 2012 19 890 895 10.1016/j.phymed.2012.04.001
18. Klein K. A., Reiter R. E., Redula J., Moradi H., Zhu X. L., Brothman A. R., Lamb D. J., Marcelli M., Belldegrun A., Witte O. N., Sawyers C. L., Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nature Medicine 1997 3 4 402 408 2-s2.0-16944366096 10.1038/nm0497-402 (Pubitemid 27145681)
19. Hayward S. W., Dahiya R., Cunha G. R., Bartek J., Deshpande N., Narayan P., Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cellular & Developmental Biology 1995 31 1 14 24 2-s2.0-0029202881 10.1007/BF02631333
20. Ghantous A., Gali-Muhtasib H., Vuorela H., Saliba N. A., Darwiche N., What made sesquiterpene lactones reach cancer clinical trials? Drug Discovery Today 2010 15 15-16 668 678 2-s2.0-77955517585 10.1016/j.drudis.2010.06.002
21. Maalouf S. W., Talhouk R. S., Schanbacher F. L., Inflammatory responses in epithelia: endotoxin-induced IL-6 secretion and iNOS/NO production are differentially regulated in mouse mammary epithelial cells. Journal of Inflammation 2010 7, article 58 2-s2.0-78649490645 10.1186/1476-9255-7-58
22. Talhouk R. S., Chin J. R., Unemori E. N., Werb Z., Bissell M. J., Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 1991 112 2 439 449
23. 2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proceedings of the National Academy of Sciences of the United States of America 2000 97 13 7494 7499 2-s2.0-0034690807 10.1073/pnas.97.13.7494 (Pubitemid 30431491)
24. 1 " peaks on DNA content histograms. Cytometry A 2007 71 3 125 131 2-s2.0-33847642110 10.1002/cyto.a.20357 (Pubitemid 46355337)
25. Naryzhny S. N., Proliferating cell nuclear antigen: a proteomics view. Cellular and Molecular Life Sciences 2008 65 23 3789 3808 2-s2.0-57349184695 10.1007/s00018-008-8305-x
26. Los M., Mozoluk M., Ferrari D., Stepczynska A., Stroh C., Renz A., Herceg Z., Wang Z. Q., Schulze-Osthoff K., Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Molecular Biology of the Cell 2002 13 3 978 988 2-s2.0-0036196425 10.1091/mbc.01-05-0272 (Pubitemid 34250359)
27. Dinarello C. A., Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology 2009 27 519 550 2-s2.0-62649139025 10.1146/annurev.immunol.021908.132612
28. Karin M., Nuclear factor- B in cancer development and progression. Nature 2006 441 7092 431 436 2-s2.0-33745298519 10.1038/nature04870 (Pubitemid 44050137)
29. Hollebeeck S., Raas T., Piront N., Schneider Y. J., Toussaint O., Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model. Toxicology Letters 2011 206 3 268 275 10.1016/j.toxlet.2011.08.010
30. Jacob S. W., Herschler R., Pharmacology of DMSO. Cryobiology 1986 23 1 14 27 2-s2.0-0022575629 (Pubitemid 16130859)
31. Santos N. C., Figueira-Coelho J., Martins-Silva J., Saldanha C., Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochemical Pharmacology 2003 65 7 1035 1041 2-s2.0-0037379110 10.1016/S0006-2952(03)00002-9 (Pubitemid 36349743)
32. Galderisi U., Jori F. P., Giordano A., Cell cycle regulation and neural differentiation. Oncogene 2003 22 33 5208 5219 2-s2.0-0041967156 10.1038/sj.onc.1206558 (Pubitemid 37059602)
33. Romani A. A., Desenzani S., Morganti M. M., La Monica S., Borghetti A. F., Soliani P., Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells. Biochemical Pharmacology 2009 78 2 133 141 2-s2.0-67349101234 10.1016/j.bcp.2009.04.004
34. Gross O., Thomas C. J., Guarda G., Tschopp J., The inflammasome: an integrated view. Immunological Reviews 2011 243 1 136 151 10.1111/j.1600-065X. 2011.01046.x
35. Sauter K. A. D., Wood L. J., Wong J., Iordanov M., Magun B. E., Doxorubicin and daunorubicin induce processing and release of interleukin-1 β through activation of the NLRP3 inflammasome. Cancer Biology and Therapy 2011 11 12 1008 1016 2-s2.0-79958811218 10.4161/cbt.11.12.15540
36. Travnicek Z., Vanco J., Hosek J., Buchtik R., Dvorak Z., Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells. Chemistry Central Journal 2012 6, article 160 10.1186/1752-153X-6-160
37. Galati G., O'Brien P. J., Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radical Biology and Medicine 2004 37 3 287 303 2-s2.0-3042574709 10.1016/j.freeradbiomed.2004.04.034 (Pubitemid 38833996)
38. Havsteen B. H., The biochemistry and medical significance of the flavonoids. Pharmacology & Therapeutics 2002 96 2-3 67 202 2-s2.0-0036849077 10.1016/S0163-7258(02)00298-X (Pubitemid 35356564)
39. Maneechai S., De-Eknamkul W., Umehara K., Noguchi H., Likhitwitayawuid K., Flavonoid and stilbenoid production in callus cultures of Artocarpus lakoocha. Phytochemistry 2012 81 42 49
40. Park K. H., Park Y. D., Han J. M., Im K. R., Lee B. W., Jeong I. Y., Jeong T. S., Lee W. S., Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata. Bioorganic & Medicinal Chemistry Letters 2006 16 21 5580 5583 2-s2.0-33748933010 10.1016/j.bmcl.2006.08.032 (Pubitemid 44430057)
41. Lee H. J., Lyu D. H., Koo U., Nam K. W., Hong S. S., Protection of prenylated flavonoids from mori cortex radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y Cells. Archives of Pharmacal Research 2012 35 1 163 170 10.1007/s12272-012-0118-7
42. Yang Z. G., Matsuzaki K., Takamatsu S., Kitanaka S., Inhibitory effects of constituents from Morus alba var. multicaulis on differentiation of 3T3-L1 cells and nitric oxide production in RAW264.7 cells. Molecules 2011 16 7 6010 6022 2-s2.0-79960767433 10.3390/molecules16076010